Board

BOARD

board

Paolo Rossi

paoloPaolo Rossi

Paolo is Immunologist and Professor of Paediatrics University of Rome. He dedicated most of his career to congenital immunodeficiency pathogenesis. Particularly, in the field of HIV, he performed significant research on MTCT mechanisms, HIV molecular diagnosis in infants, and analysis of immunological mechanisms correlating to early ART. Paolo coordinated the only HIV therapeutic vaccine trial conducted in HIV infected children. He published more than 260 papers in peer-reviewed journals.

Diana Gibb

diana-gibbDiana Gibb

Diana is a paediatrician, epidemiologist and programme leader of a large paediatric programme of trials and cohorts worldwide in HIV and other infections (eg sepsis and malaria in Africa). She has been working with the PENTA network since its foundation more than 20 years ago and was pivotal in setting up and coordinating the network of clinical trials and cohorts across Europe, Thailand and South America which, to date, has mainly focused on paediatric HIV infection. She undertook research on paediatric HCV infection transmission and natural history in UK and Ireland and continues to collaborate in the ongoing follow-up of the paediatric cohort with Professor Mary Ramsay at Public Health England.

Carlo Giaquinto

carlo-giaquintoCarlo Giaquinto

Carlo is the President of PENTA Foundation and Associate Professor of Paediatrics at the University of Padua (Italy). Head of the paediatric HIV clinical trial unit of Padua Hospital, he is author of more than 220 papers in peer-reviewed journals.

Michael Sharland

michael-sharlandMicheal Sharland

Micheal has a research interest in optimising antimicrobial prescribing in children. He is the joint Chair of PENTA. He was the previous Chair of the ESPID Research Committee. In the UK, he Chairs the Royal College of Paediatrics and Child Health Infection Committee. He is the Chief Advisor on anti-infectives to the Children’s British National Formulary. He also Chairs the Department of Health’s advisory committee, Antimicrobial Resistance and Healthcare Associated Infection, which advises the UK government on antimicrobial use and resistance. He has published 220 papers on the optimal use of antimicrobials in children. He was the Chief Investigator of ARPEC, and is the CI of NeoVanc Project and of CAP-IT in the UK.

Claire Thorne

claire-thorneClaire Thorne

Claire is an infectious disease epidemiologist with a particular focus on maternal and child health. She has a research programme on the epidemiology of HIV and viral hepatitis in women and children, with clinical and epidemiological networks in the UK and elsewhere in Europe, including large networks in Eastern Europe. She has 20 years of experience of working on observational cohort studies of pregnant women and children, including coordination of European cohort collaborations on paediatric HIV/HCV co-infection and HIV in pregnancy. Claire published over 110 journal articles to date.